Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4

被引:19
|
作者
Wallace, M [1 ]
Ball, KL [1 ]
机构
[1] Univ Dundee, Sch Med, CRUK Labs, Dundee DD1 9SY, Scotland
关键词
D O I
10.1128/MCB.24.12.5606-5619.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphorylation of target proteins by cyclin D1-Cdk4 requires both substrate docking and kinase activity. In addition to the ability of cyclin D1-Cdk4 to catalyze the phosphorylation of consensus sites within the primary amino acid sequence of a substrate, maximum catalytic activity requires the enzyme complex to anchor at a site remote from the phospho-acceptor site. A novel Cdk4 docking motif has been defined within a stretch of 19 amino acids from the C-terminal domain of the Rb protein that are essential for Cdk4 binding. Mutation or deletion of the docking motif prevents Cdk4-dependent phosphorylation of full-length Rb protein or C-terminal Rb fragments in vitro and in cells, while a peptide encompassing the Cdk4 docking motif specifically inhibits Cdk4-dependent phosphorylation of Rb. Cyclin D1-Cdk4 can overcome the growth-suppressive activity of Rb in both cell cycle progression and colony formation assays; however, while mutants of Rb in which the Cdk4 docking site has been either deleted or mutated retain growth suppressor activity, they are resistant to inactivation by cyclin D1-Cdk4. Finally, binding of Cdk4 to its docking site can inhibit cleavage of exogenous and endogenous Rb in response to distinct apoptotic signals. The Cdk4 docking motif in Rb gives insight into the mechanism by which enzyme specificity is ensured and highlights a role for Cdk4 docking in maintaining the Rb protein in a form that favors cell survival rather than apoptosis.
引用
收藏
页码:5606 / 5619
页数:14
相关论文
共 50 条
  • [1] Docking-dependent Ubiquitination of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by the Ubiquitin Ligase CHIP
    Narayan, Vikram
    Pion, Emmanuelle
    Landre, Vivien
    Mueller, Petr
    Ball, Kathryn L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (01) : 607 - 619
  • [2] Regulation of CDK4
    Bockstaele, Laurence
    Coulonval, Katia
    Kooken, Hugues
    Paternot, Sabine
    Roger, Pierre P.
    CELL DIVISION, 2006, 1 (1)
  • [3] Regulation of CDK4
    Laurence Bockstaele
    Katia Coulonval
    Hugues Kooken
    Sabine Paternot
    Pierre P Roger
    Cell Division, 1
  • [4] Several noncontiguous domains of CDK4 are involved in binding to the p16 tumor suppressor protein
    Ceha, HM
    Nasser, I
    Medema, RH
    Slebos, RJC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) : 550 - 555
  • [5] Trilaciclib, a CDK4/6 inhibitor, does not impair the efficacy of chemotherapy in CDK4/6-dependent tumor models
    Sorrentino, J.
    Bisi, J.
    Thompson, D.
    Lai, A.
    Strum, J.
    Roberts, P.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E47 - E48
  • [6] Amplification of the CDK4 gene in sarcomas: Tumor specificity and relationship with the RB gene mutation
    Kanoe, H
    Nakayama, T
    Murakami, H
    Hosaka, T
    Yamamoto, H
    Nakashima, Y
    Tsuboyama, T
    Nakamura, T
    Sasaki, MS
    Toguchida, J
    ANTICANCER RESEARCH, 1998, 18 (4A) : 2317 - 2321
  • [7] Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme
    Rollbrocker, B
    Waha, A
    Louis, DN
    Wiestler, OD
    vonDeimling, A
    ACTA NEUROPATHOLOGICA, 1996, 92 (01) : 70 - 74
  • [8] Hernandezine acts as a CDK4 suppressor inhibiting tumor growth by the CDK4/PKM2/NRF2 axis in colon cancer
    Lv, Jun-lin
    Ren, Yu-shan
    Tan, Yu-jun
    Chu, Ting
    Cao, Xin-yue
    Liu, Huai-yuan
    Ma, Ru
    Zhang, Han
    Zheng, Qiu-sheng
    Dong, Gui-cheng
    Li, Jie
    PHYTOMEDICINE, 2024, 131
  • [9] Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein
    Ikuta, M
    Kamata, K
    Fukasawa, K
    Honma, T
    Machida, T
    Hirai, H
    Suzuki-Takahashi, I
    Hayama, T
    Nishimura, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) : 27548 - 27554
  • [10] Performance of protein-ligand docking with CDK4/6 inhibitors: a case study
    Song, Linlu
    Ning, Shangbo
    Hou, Jinxuan
    Zhao, Yunjie
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2020, 18 (01) : 456 - 470